These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20960105)

  • 1. Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study.
    Küpeli E; Ulubay G; Ulasli SS; Sahin T; Erayman Z; Gürsoy A
    Endocrine; 2010 Aug; 38(1):76-82. PubMed ID: 20960105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs.
    Choi HS; Rhee CK; Park YB; Yoo KH; Lim SY
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2873-2883. PubMed ID: 31849460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study.
    Keeratichananont W; Kaenmuang P; Geater SL; Manoret P; Thanapattaraborisuth B
    Ther Adv Respir Dis; 2023; 17():17534666231167342. PubMed ID: 37086118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome prevalence in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease: Relationship with systemic inflammation.
    Zhou W; Li CL; Cao J; Feng J
    Clin Respir J; 2020 Dec; 14(12):1159-1165. PubMed ID: 32777167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD.
    Minas M; Mystridou P; Georgoulias P; Pournaras S; Kostikas K; Gourgoulianis KI
    COPD; 2013 Feb; 10(1):28-34. PubMed ID: 23272665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease: An observational study in South Indians.
    Priyadharshini N; Renusha RC; Reshma S; Sindhuri Sai M; Koushik Muthu RM; Rajanandh MG
    Diabetes Metab Syndr; 2020; 14(4):503-507. PubMed ID: 32388329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonia as comorbidity in chronic obstructive pulmonary disease (COPD). Differences between acute exacerbation of COPD and pneumonia in patients with COPD.
    Boixeda R; Bacca S; Elias L; Capdevila JA; Vilà X; Mauri M; Almirall J
    Arch Bronconeumol; 2014 Dec; 50(12):514-20. PubMed ID: 25443591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Cardiovascular Events Associated with Chronic Obstructive Pulmonary Disease and/or Metabolic Syndrome: A Large-Scale Nationwide Population-Based Cohort Study.
    Noh E; Jeong H; Cho IS; Chang MS; Yu I; Park S; Lee JH; Lee SJ; Lee WY; Yong SJ; Kim SH
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1447-1456. PubMed ID: 38948908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.
    Chan SMH; Selemidis S; Bozinovski S; Vlahos R
    Pharmacol Ther; 2019 Jun; 198():160-188. PubMed ID: 30822464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased systemic inflammation is a risk factor for COPD exacerbations.
    Groenewegen KH; Postma DS; Hop WC; Wielders PL; Schlösser NJ; Wouters EF;
    Chest; 2008 Feb; 133(2):350-7. PubMed ID: 18198263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Syndrome in Patients with Coexistent Obstructive Sleep Apnea Syndrome and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).
    Archontogeorgis K; Voulgaris A; Papanas N; Nena E; Xanthoudaki M; Pataka A; Schiza S; Rizzo M; Froudarakis ME; Steiropoulos P
    Metab Syndr Relat Disord; 2020 Aug; 18(6):296-301. PubMed ID: 32379990
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic inflammation and metabolic syndrome in stable COPD patients.
    Akpınar EE; Akpınar S; Ertek S; Sayın E; Gülhan M
    Tuberk Toraks; 2012; 60(3):230-7. PubMed ID: 23030748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPD patients with and without metabolic syndrome: clinical and functional differences.
    Díez-Manglano J; Barquero-Romero J; Almagro P; Cabrera FJ; López García F; Montero L; Soriano JB;
    Intern Emerg Med; 2014 Jun; 9(4):419-25. PubMed ID: 23645508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive performance in relation to metabolic disturbances in patients with COPD.
    van Beers M; Gosker HR; Janssen DJA; Cleutjens FAHM; Franssen FME; van Boxtel MPJ; Wouters EF; Ponds RWHM; Schols AMWJ
    Clin Nutr; 2021 Apr; 40(4):2061-2067. PubMed ID: 33041090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D.
    Piazzolla G; Castrovilli A; Liotino V; Vulpi MR; Fanelli M; Mazzocca A; Candigliota M; Berardi E; Resta O; Sabbà C; Tortorella C
    PLoS One; 2017; 12(10):e0186708. PubMed ID: 29065130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.
    MacLeod M; Papi A; Contoli M; Beghé B; Celli BR; Wedzicha JA; Fabbri LM
    Respirology; 2021 Jun; 26(6):532-551. PubMed ID: 33893708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review.
    Cebron Lipovec N; Beijers RJ; van den Borst B; Doehner W; Lainscak M; Schols AM
    COPD; 2016 Jun; 13(3):399-406. PubMed ID: 26914392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome in South Korean Patients with Chronic Obstructive Pulmonary Disease: A Focus on Gender Differences.
    Kim J; Yoo JY; Kim HS
    Asian Nurs Res (Korean Soc Nurs Sci); 2019 May; 13(2):137-146. PubMed ID: 30910730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.